SFU Forschungs- & Publikationsdatenbank

2018
Sykora, M., Putaala, J., Tatlisumak, T., & Strbian, D. (2018). Beta-blocker therapy is not associated with mortality after intracerebral hemorrhage. Acta Neurol Scand, 137(1), 105-108. doi: 10.1111/ane.12817
Szabo, J., Smielewski, P., Czosnyka, M., Jakubicek, S., Krebs, S., Siarnik, P., & Sykora, M. (2018). Heart rate variability is associated with outcome in spontaneous intracerebral hemorrhage. J Crit Care, 48, 85-89. doi: 10.1016/j.jcrc.2018.08.033
Tajsic, M., Jarai, R., Koch, J., Stangl, K., Wojta, J., Dreger, H., & Huber, K. (2018). Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome - The WilCop study. Int J Cardiol, 273, 243–248. doi: 10.1016/j.ijcard.2018.09.084
Teuschl, S. L. (2018). Empathie als neurobiologisch codierte Information und der verbesserte Schutz von Patienteninformationen in psychotherapeutischen Gutachten. SFU Forschungsbulletin, 6(2), 9-26. doi: https://doi.org/10.15135/2018.6.2.9-26
Thabrew, H., Sawyer, A., & Eichenberg, C. (2018). Patient-Targeted Googling by New Zealand Mental Health Professionals: A New Field Of Ethical Consideration in the Internet Age. Telemedicine J E Health, 24(10), 818-824. doi: 10.1089/tmj.2017.0247
Thiele, H., Sandri, M., Waha-Thiele, S., Fuernau, G., Eitel, I., Nordbeck, P., Geisler, T., Landmesser, U., Skurk, C., Fach, A., Jobs, A., Lapp, H., Piek, J. J., Noc, M., Goslar, T., Felix, S. B., Maier, L. S., Stepinska, J., Oldroyd, K., Serpytis, P., Montalescot, G., Barthelemy, O., Huber, K., Windecker, S., Hunziker, L., Savonitto, S., Torremante, P., Vrints, C., Schneider, S., Zeymer, U., Desch, S., & Culprit-Shock, I. (2018). One-Year Outcomes after PCI Strategies in Cardiogenic Shock. N Engl J Med, 379(18), 1699-1710. doi: 10.1056/NEJMoa1808788
Tichy, H. E. (2018). Die Kunst präsent zu sein. Carl Rogers und das frühbuddhistische Verständnis von Meditation. Psychotherapiewissenschaft in Forschung, Profession und Kultur / Schriftenreihe der Sigmund-Freud-Privatuniversität Wien, Vol. 22 (Ed.: Bernd Rieken). Münster: Waxmann.
Tiefenböck, T., Boesmüller, S., Popp, D., Payr, S., Joestl, J., Binder, H., Schurz, M., Komjati, M., Fialka, C., & Ostermann, R. (2018). The use of the LARS system in the treatment of AC joint instability - Long-term results after a mean of 7.4 years. Orthop Traumatol Surg Res, 104(6), 749-754. doi: 10.1016/j.otsr.2018.02.010
Toell, T., Boehme, C., Mayer, L., Krebs, S., Lang, C., Wileit, K., Prantl, B., Knoflach, M., Rumpold, G., Schoenherr, G., Griesmacher, A., Willeit, P., Ferrari, J., Lang, W., Kiechl, S., & Willeit, J. (2018). Pragmatic trial of multifaceted intervention (STROKE-CARD care) to reduce cardiovascular risk and improve quality-of-life after ischaemic stroke and transient ischaemic attack -study protocol. BMC Neurol, 18(1), Epub. doi: 10.1186/s12883-018-1185-2
Trenti, E., Palermo, S., D'elia, C., Comploj, E., Pycha, A., Carella, R., & Pycha, A. (2018). Malignant mesothelioma of tunica vaginalis testis: Report of a very rare case with review of the literature. Arch Ital Urol Androl, 2018(90), 212-214. doi: 10.4081/aiua.2018.3.212
Tscharre, M., Herman, R., Rohla, M., Hauser, C., Farhan, S., Freynhofer, M., Huber, K., & Weiss, T. (2018). Uric acid is associated with long-term adverse cardiovascular outcomes in patients with acute coronary syndrome undergoing percutaneous coronary intervention. Atherosclerosis, 270, 173-179. doi: 10.1016/j.atherosclerosis.2018.02.003
Tymko, M., Donnelly, J., Smielewski, P., Zeiler, F., Sykora, M., Haubrich, C., Nasr, N., & Czosnyka, M. (2018). Changes in cardiac autonomic activity during intracranial pressure plateau waves in patients with traumatic brain injury. Clin Auton Res, 29(1), 123–126. doi: 10.1007/s10286-018-0579-y
Uhl, A., Busch, M., Springer, A., & Weigl, M. (2018). Cannabisregulierung in Österreich. Suchtmedizin, 20(6), 374 – 382.
Uhlmann, M., Walter, C., Taher, F., Plimon, M., Falkensammer, J., & Assadian, A. (2018). Successful percutaneous access for endovascular aneurysm repair is significantly cheaper than femoral cutdown in a prospective randomized trial. J Vasc Surg, 68(2), 384-391. doi: 10.1016/j.jvs.2017.12.052
Uschner, D., Hilgers, R., & Heussen, N. (2018). The impact of selection bias in randomized multi-arm parallel group clinical trials. PLOS ONE, 13(1), e0192065. doi: 10.1371/journal.pone.0192065 (IF: 2.806)
Valdiglesias, V., Marcos-Pérez, D., Lorenzi, M., Onder, G., Gostner, J. M., Strasser, B., Fuchs, D., & Bonassi, S. (2018). Immunological alterations in frail older adults: A cross sectional study. Experimental Gerontology, 112, 119-126. doi: 10.1016/j.exger.2018.09.010 (IF: 3.224)
Van Den Hoogen, L. L., Palla, G., Bekker, C. P. J., Fritsch-Stork, R. D. E., Radstake, T. R. D. J., & Van Roon, J. A. G. (2018). Increased B-cell activating factor (BAFF)/B-lymphocyte stimulator (BLyS) in primary antiphospholipid syndrome is associated with higher adjusted global antiphospholipid syndrome scores. RMD Open, 4(2), e000693. doi: 10.1136/rmdopen-2018-000693
Van Den Hoogen, L. L., Van Der Heijden, E. H. M., Hillen, M. R., Mertens, J. S., Fritsch-Stork, R. D. E., Radstake, T. R. D. J., & Van Roon, J. A. G. (2018). Galectin-9 reflects the interferon signature and correlates with disease activity in systemic autoimmune diseases. Ann Rheum Dis, -(Epub), -. doi: 10.1136/annrheumdis-2018-214651
Van Den Hoogen, L., Van Roon, J., Mertens, J., Wienke, J., Lopes, A., De Jager, W., Rossato, M., Pandit, A., Wichers, C., Van Wijk, F., Fritsch-Stork, R., & Radstake, T. (2018). Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis, 77(12), 1810-1814. doi: 10.1136/annrheumdis-2018-213497
Van Der Linden, M., Van Den Hoogen, L., Westerlaken, G., Fritsch-Stork, R., Van Roon, J., Radstake, T., & Meyaard, L. (2018). Neutrophil extracellular trap release is associated with antinuclear antibodies in systemic lupus erythematosus and anti-phospholipid syndrome. Rheumatology, 57(7), 1228–1234. doi: 10.1093/rheumatology/key067
Venerosi, A., Michelini, G., Salinetti, S., Bertelli, M., Cottini, L., Nardocci, F., Moroni, M., Pellegrini, P., & Leoni, M. (2018). Bisogni e servizi per la qualità di vita delle persone con disabilità: risultato di uno studio nella provincia di Parma. Rapporti ISTISAN, 18(14), 1-56. http://old.iss.it/binary/publ/cont/18_14_web.pdf
Vetterlein, M., Gild, P., Kluth, L., Seisen, T., Gierth, M., Fritsche, H., Burger, M., Protzel, C., Hakenberg, O., Von Landenberg, N., Roghmann, F., Noldus, J., Nuhn, P., Pycha, A., Rink, M., Chun, F., May, M., Fisch, M., Aziz, A., & Prometrics 2011 Study Group, .. (2018). Peri-operative allogeneic blood transfusion does not adversely affect oncological outcomes after radical cystectomy for urinary bladder cancer: a propensity score-weighted European multicentre study. BJU Int, 121(1), 101-110. doi: 10.1111/bju.14012
Voitl, P. (2018). K(l)assenpädiatrie“ – quo vadis?. Monatsschr Kinderheilkd, 166(9), 760-766. doi: 10.1007/s00112-018-0514-2
Voitl, P. (2018). Medizinisches Cannabis in der Pädiatrie. MONATSSCHRIFT KINDERHEILKUNDE, 166(12), 1073-1074. doi: 10.1007/s00112-018-0601-4
Vranckx, P., Valgimigli, M., Jüni, P., Hamm, C., Steg, P., Heg, D., Van Es, G., Mcfadden, E., Onuma, Y., Van Meijeren, C., Chichareon, P., Benit, E., Möllmann, H., Janssens, L., Ferrario, M., Moschovitis, A., Zurakowski, A., Dominici, M., Van Geuns, R., Huber, K., Sagboom, T., Serruys, P., & Windecker, S. (2018). Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-la. The Lancet, 392(10151), 940-949. doi: 10.1016/S0140-6736(18)31858-0